{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:47:48Z","timestamp":1784594868388,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T00:00:00Z","timestamp":1537747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Henan medical science and technology research project","award":["201702105"],"award-info":[{"award-number":["201702105"]}]},{"name":"University Key Project of Henan Province","award":["15A320064"],"award-info":[{"award-number":["15A320064"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Long noncoding RNAs (LncRNAs) have been reported to be abnormally\nexpressed in human ovarian cancer and associated with the proliferation and\nmetastasis of cancer cells. The objective of this study was to investigate the\nrole and the underlying mechanisms of LncRNA MAP3K20 antisense RNA 1 (MLK7-AS1)\nin ovarian cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The expression level of MLK7-AS1 was investigated in human ovarian\ncancer tissues and cell lines. The effects of MLK7-AS1 knockdown on ovarian\ncancer cell proliferation, migration, invasion and apoptosis were evaluated in\nvitro using MTT, colony formation assays, wound healing assays, transwell assays\nand flow cytometry. Furthermore, the in vivo effects were determined using the\nimmunodeficient NSG female mice. Luciferase reporter assays were employed to\nidentify interactions among MLK7-AS1 and its target genes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the current study, MLK7-AS1 was specifically upregulated in\novarian cancer tissues and cell lines. Knockdown of MLK7-AS1 inhibited the\nability of cell migration, invasion, proliferation, colony formation and wound\nhealing, whereas promoted cell apoptosis in vitro. By using online tools and\nmechanistic analysis, we demonstrated that MLK7-AS1 could directly bind to\nmiR-375 and downregulate its expression. Besides, MLK7-AS1 reversed the\ninhibitory effect of miR-375 on the growth of ovarian cancer cells, which might\nbe involved in the upregulation of Yes-associated protein 1 (YAP1) expression.\nMoreover, knockdown MLK7-AS1 expression inhibited primary tumor growth in ovary\nand metastatic tumors in multiple peritoneal organs including liver and spleen\nin vivo, which were partly abolished by miR-375 inhibition. Mechanically, we\nfound that MLK7-AS1 modulated the epithelial-mesenchymal transition (EMT)\nprocess by interacting with miR-375\/YAP1 both in vivo and vitro, which promoted\nthe expression of Slug.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Taken together, our study showed for the first time that MLK7-AS1\ninteracted with miR-375 to promote proliferation, metastasis, and EMT process in\novarian cancer cells through upregulating YAP1.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13046-018-0910-4","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T09:20:53Z","timestamp":1537780853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["RETRACTED ARTICLE: Long noncoding RNA MLK7-AS1 promotes ovarian\ncancer cells progression by modulating miR-375\/YAP1 axis"],"prefix":"10.1186","volume":"37","author":[{"given":"Huan","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"issue":"7","key":"910_CR1","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.cell.2017.11.040","volume":"171","author":"Y Hosono","year":"2017","unstructured":"Hosono Y, Niknafs YS, Prensner JR, et al. Oncogenic role of THOR, a\nconserved Cancer\/testis long non-coding RNA. Cell.\n2017;171(7):1559\u201372.","journal-title":"Cell"},{"issue":"4","key":"910_CR2","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"A Schmitt","year":"2016","unstructured":"Schmitt A, Chang H. Long noncoding RNAs in Cancer pathways. Cancer\nCell. 2016;29(4):452\u201363.","journal-title":"Cancer Cell"},{"issue":"3","key":"910_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.cell.2004.07.011","volume":"118","author":"Y Kang","year":"2004","unstructured":"Kang Y, Massagu\u00e9 J. Epithelial-mesenchymal transitions: twist in\ndevelopment and metastasis. Cell. 2004;118(3):277\u20139.","journal-title":"Cell"},{"issue":"1","key":"910_CR4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12943-017-0643-6","volume":"16","author":"W Wang","year":"2017","unstructured":"Wang W, He X, Zheng Z, et al. Serum HOTAIR as a novel diagnostic\nbiomarker for esophageal squamous cell carcinoma. Mol Cancer.\n2017;16(1):75.","journal-title":"Mol Cancer"},{"issue":"3","key":"910_CR5","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1159\/000488841","volume":"46","author":"B Zeng","year":"2018","unstructured":"Zeng B, Lin Z, Ye H, et al. Upregulation of LncDQ is associated\nwith poor prognosis and promotes tumor progression via epigenetic regulation of\nthe EMT pathway in HCC. Cell Physiol Biochem.\n2018;46(3):1122\u201333.","journal-title":"Cell Physiol Biochem"},{"issue":"4","key":"910_CR6","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/jcb.26021","volume":"119","author":"Z Rong","year":"2018","unstructured":"Rong Z, Jin H, Fan L. The long non-coding RNA TP73-AS1 interacted\nwith miR-142 to modulate brain glioma growth through HMGB1\/RAGE pathway. J Cell\nBiochem. 2018;119(4):3007\u201316.","journal-title":"J Cell Biochem"},{"issue":"2","key":"910_CR7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.bbrc.2003.09.075","volume":"310","author":"X Yu","year":"2003","unstructured":"Yu X, Bloem LJ. Effect of C-terminal truncations on MLK7 catalytic\nactivity and JNK activation. Biochem Biophys Res Commun.\n2003;310(2):452\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"910_CR8","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1006\/jmcc.2001.1437","volume":"33","author":"LJ Bloem","year":"2001","unstructured":"Bloem LJ, Pickard TR, Acton S, et al. Tissue distribution and\nfunctional expression of a cDNA encoding a novel mixed lineage kinase. J Mol\nCell Cardiol. 2001;33(9):1739\u201350.","journal-title":"J Mol Cell Cardiol"},{"key":"910_CR9","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.12659\/MSM.901190","volume":"22","author":"R Wu","year":"2016","unstructured":"Wu R, Jian Z, Wei L, et al. A tumor-specific prognostic long\nnon-coding RNA signature in gastric Cancer. Med Sci Monit.\n2016;22:3647\u201357.","journal-title":"Med Sci Monit"},{"issue":"2","key":"910_CR10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.bbrc.2018.02.072","volume":"497","author":"Y Quan","year":"2018","unstructured":"Quan Y, Zhang Y, Lin W, et al. Knockdown of long non-coding RNA\nMAP3K20 antisense RNA 1 inhibits gastric cancer growth through epigenetically\nregulating miR-375. Biochem Biophys Res Commun.\n2018;497(2):527\u201334.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"910_CR11","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1158\/1078-0432.CCR-14-2191","volume":"21","author":"S Song","year":"2015","unstructured":"Song S, Honjo S, Jin J, et al. The hippo coactivator YAP1 mediates\nEGFR overexpression and confers Chemoresistance in esophageal Cancer. Clin\nCancer Res. 2015;21(11):2580\u201390.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"910_CR12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00018-014-1742-9","volume":"72","author":"M Kodaka","year":"2015","unstructured":"Kodaka M, Hata Y. The mammalian hippo pathway: regulation and\nfunction of YAP1 and TAZ. Cell Mol Life Sci.\n2015;72(2):285\u2013306.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"910_CR13","doi-asserted-by":"crossref","first-page":"e1118","DOI":"10.3390\/ijms19041118","volume":"19","author":"X Zhao","year":"2018","unstructured":"Zhao X, Sun J, Su W, et al. Melatonin protects against lung\nfibrosis by regulating the hippo\/YAP pathway. Int J Mol Sci.\n2018;19(4):e1118.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"910_CR14","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.bbrc.2018.02.006","volume":"496","author":"HY Zhu","year":"2018","unstructured":"Zhu HY, Bai WD, Ye XM, et al. Long non-coding RNA UCA1 desensitizes\nbreast cancer cells to trastuzumab by impeding miR-18a repression of\nyes-associated. Protein 1. Biochem Biophys Res Commun.\n2018;496(4):1308\u201313.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"910_CR15","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/jcb.26343","volume":"119","author":"X Jin","year":"2018","unstructured":"Jin X, Ma B, Gong C, et al. MicroRNA-622 suppresses the\nproliferation of glioma cells by targeting YAP1. J Cell Biochem.\n2018;119(3):2492\u2013500.","journal-title":"J Cell Biochem"},{"issue":"3","key":"910_CR16","first-page":"1094","volume":"53","author":"K Mou","year":"2018","unstructured":"Mou K, Liu B, Ding M, et al. LncRNA-ATB functions as a competing\nendogenous RNA to promote YAP1 by sponging miR-590-5p in malignant melanoma. Int\nJ Oncol. 2018;53(3):1094\u2013104.","journal-title":"Int J Oncol"},{"issue":"1","key":"910_CR17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cell.2014.06.004","volume":"158","author":"DD Shao","year":"2014","unstructured":"Shao DD, Xue W, Krall EB, et al. KRAS and YAP1 converge to regulate\nEMT and tumor survival. Cell. 2014;158(1):171\u201384.","journal-title":"Cell"},{"issue":"22","key":"910_CR18","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1038\/s41388-018-0204-5","volume":"37","author":"J Shi","year":"2018","unstructured":"Shi J, Li F, Yao X, et al. The HER4-YAP1 axis promotes trastuzumab\nresistance in HER2-positive gastric cancer by inducing epithelial and\nmesenchymal transition [J]. Oncogene. 2018;37(22):3022\u201338.","journal-title":"Oncogene"},{"issue":"37","key":"910_CR19","doi-asserted-by":"crossref","first-page":"E2441","DOI":"10.1073\/pnas.1212021109","volume":"109","author":"JM Lamar","year":"2012","unstructured":"Lamar JM, Hynes RO. The hippo pathway target, YAP, promotes\nmetastasis through its TEAD-interaction domain. Proc Natl Acad Sci U S A.\n2012;109(37):E2441\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"910_CR20","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jcb.26231","volume":"119","author":"J Yao","year":"2018","unstructured":"Yao J, Xu F, Zhang D, et al. TP73-AS1 promotes breast cancer cell\nproliferation through miR-200a-mediated TFAM inhibition. J Cell Biochem.\n2018;119(1):680\u201390.","journal-title":"J Cell Biochem"},{"issue":"1","key":"910_CR21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-016-0420-1","volume":"35","author":"DL Chen","year":"2016","unstructured":"Chen DL, Ju HQ, Lu YX, et al. Long non-coding RNA XIST regulates\ngastric cancer progression by acting as a molecular sponge of miR-101 to\nmodulate EZH2 expression. J Exp Clin Cancer Res.\n2016;35(1):142.","journal-title":"J Exp Clin Cancer Res"},{"key":"910_CR22","doi-asserted-by":"publisher","unstructured":"Yan H, Maria AS, Li H, et al. Long noncoding RNA DQ786243 interacts\nwith miR-506 and promotes progression of ovarian cancer through targeting cAMP\nresponsive element binding protein 1. J Cell Biochem. 2018. https:\/\/doi.org\/10.1002\/jcb.27295.","DOI":"10.1002\/jcb.27295"},{"issue":"1","key":"910_CR23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cam4.347","volume":"4","author":"A Fukagawa","year":"2015","unstructured":"Fukagawa A, Ishii H, Miyazawa K, et al. \u03b4EF1 associates with DNMT1\nand maintains DNA methylation of the E-cadherin promoter in breast cancer cells.\nCancer Med. 2015;4(1):125\u201335.","journal-title":"Cancer Med"},{"issue":"3","key":"910_CR24","first-page":"517","volume":"17","author":"S Natsugoe","year":"2007","unstructured":"Natsugoe S, Uchikado Y, Okumura H, et al. Snail plays a key role in\nE-cadherin-preserved esophageal squamous cell carcinoma. Oncol Rep.\n2007;17(3):517\u201323.","journal-title":"Oncol Rep"},{"key":"910_CR25","doi-asserted-by":"crossref","unstructured":"Wang B, Lv K, Chen W, et al. miR-375 and miR-205 regulate the\ninvasion and migration of laryngeal squamous cell carcinoma synergistically via\nAKT-mediated EMT. Biomed Res Int 2016; 2016:9652789.","DOI":"10.1155\/2016\/9652789"},{"issue":"5","key":"910_CR26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/IGC.0000000000000711","volume":"26","author":"X Yu","year":"2016","unstructured":"Yu X, Zhao W, Yang X, et al. miR-375 affects the proliferation,\ninvasion, and apoptosis of HPV16-positive human cervical Cancer cells by\ntargeting IGF-1R. Int J Gynecol Cancer. 2016;26(5):851\u20138.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"910_CR27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12943-018-0853-6","volume":"17","author":"Y Pan","year":"2018","unstructured":"Pan Y, Tong JHM, Lung RWM, et al. RASAL2 promotes tumor progression\nthrough LATS2\/YAP1 axis of hippo signaling pathway in colorectal cancer. Mol\nCancer. 2018;17(1):102.","journal-title":"Mol Cancer"},{"issue":"10","key":"910_CR28","doi-asserted-by":"crossref","first-page":"427.e1","DOI":"10.1016\/j.urolonc.2015.06.003","volume":"33","author":"S Li","year":"2015","unstructured":"Li S, Yu Z, Chen SS, et al. The YAP1 oncogene contributes to\nbladder cancer cell proliferation and migration by regulating the H19 long\nnoncoding RNA. Urol Oncol. 2015;33(10):427.e1\u201310.","journal-title":"Urol Oncol"},{"issue":"2","key":"910_CR29","first-page":"1690","volume":"8","author":"C Guo","year":"2015","unstructured":"Guo C, Wang X, Liang L. LATS2-mediated YAP1 phosphorylation is\ninvolved in HCC tumorigenesis. Int J Clin Exp Pathol.\n2015;8(2):1690\u20137.","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"910_CR30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41419-017-0134-0","volume":"9","author":"W Kang","year":"2018","unstructured":"Kang W, Huang T, Zhou Y, et al. miR-375 is involved in hippo\npathway by targeting YAP1\/TEAD4-CTGF axis in gastric carcinogenesis. Cell Death\nDis. 2018;9(2):92.","journal-title":"Cell Death Dis"},{"issue":"7579","key":"910_CR31","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature16064","volume":"527","author":"X Zheng","year":"2015","unstructured":"Zheng X, Carstens JL, Kim J, et al. Epithelial-to-mesenchymal\ntransition is dispensable for metastasis but induces chemoresistance in\npancreatic cancer. Nature. 2015;527(7579):525\u201330.","journal-title":"Nature"},{"key":"910_CR32","first-page":"4693471","volume":"2016","author":"B Liu","year":"2016","unstructured":"Liu B, Pan CF, He ZC, et al. Long noncoding RNA-LET suppresses\ntumor growth and EMT in lung adenocarcinoma. Biomed Res Int.\n2016;2016:4693471.","journal-title":"Biomed Res Int"},{"issue":"4","key":"910_CR33","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1002\/jcb.26481","volume":"119","author":"X Zheng","year":"2018","unstructured":"Zheng X, Zhang Y, Liu Y, et al. HIF-2\u03b1 activated lncRNA NEAT1\npromotes hepatocellular carcinoma cell invasion and metastasis by affecting the\nepithelial-mesenchymal transition. J Cell Biochem.\n2018;119(4):3247\u201356.","journal-title":"J Cell Biochem"},{"issue":"24","key":"910_CR34","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1038\/onc.2013.279","volume":"33","author":"SH Kao","year":"2014","unstructured":"Kao SH, Wang WL, Chen CY, et al. GSK3\u03b2 controls\nepithelial-mesenchymal transition and tumor metastasis by CHIP-mediated\ndegradation of slug. Oncogene. 2014;33(24):3172\u201382.","journal-title":"Oncogene"},{"key":"910_CR35","doi-asserted-by":"publisher","unstructured":"Meng Q, Shi S, Liang C, et al. Abrogation of glutathione\nperoxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating\nROS-mediated Akt\/GSK3\u03b2\/snail signaling. Oncogene. 2018. https:\/\/doi.org\/10.1038\/s41388-018-0392-z.","DOI":"10.1038\/s41388-018-0392-z"},{"issue":"9","key":"910_CR36","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/ncb3394","volume":"18","author":"Y Tang","year":"2016","unstructured":"Tang Y, Feinberg T, Keller ET, et al. Snail\/slug binding\ninteractions with YAP\/TAZ control skeletal stem cell self-renewal and\ndifferentiation. Nat Cell Biol. 2016;18(9):917\u201329.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"910_CR37","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41419-018-0515-z","volume":"9","author":"M Yu","year":"2018","unstructured":"Yu M, Chen Y, Li X, et al. YAP1 contributes to NSCLC invasion and\nmigration by promoting slug transcription via the transcription co-factor TEAD.\nCell Death Dis. 2018;9(5):464.","journal-title":"Cell Death Dis"}],"updated-by":[{"DOI":"10.1186\/s13046-020-01746-0","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"record-id":"24576"},{"DOI":"10.1186\/s13046-020-01746-0","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000}}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-018-0910-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-018-0910-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-018-0910-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T05:25:51Z","timestamp":1605504351000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-018-0910-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["910"],"URL":"https:\/\/doi.org\/10.1186\/s13046-018-0910-4","relation":{"retraction":[{"id-type":"doi","id":"10.1186\/s13046-020-01746-0","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,24]]},"assertion":[{"value":"16 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13046-020-01746-0","URL":"https:\/\/doi.org\/10.1186\/s13046-020-01746-0","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":".","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This human ovarian cancer sample study and in vivo study are\nethically approval by the Clinical Research Ethics Committee of the Zhengzhou\nUniversity (No. 2015\u2013158) and Institutional Committee for Animal Research of\nZhengzhou University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication the clinical and pathological data were\nobtained from all the patients that involved in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional\nclaims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"237"}}